# Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

> **NCT01829503** · PHASE2 · COMPLETED · sponsor: **Annie Im, M.D.** · enrollment: 44 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** decitabine and cytarabine
- **OTHER:** Supportive Care

## Key facts

- **NCT ID:** NCT01829503
- **Lead sponsor:** Annie Im, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-10
- **Final completion:** 2017-11-30
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01829503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01829503, "Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01829503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*